secwatch.observer — SEC 8-K summary
======================================

Issuer:     Sonoma Pharmaceuticals, Inc. (SNOA)
CIK:        0001367083
Form:       8-K
Filed at:   2023-12-29T23:59:59+00:00
Accession:  0001683168-23-009150
Event type: other_material
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Sonoma Pharmaceuticals grants 180,000 stock options to executive officers at $0.18 per share
--------------------------------------------------------------------------------

- CEO Amy Trombly, interim CFO Jerry Dvonch, and COO Bruce Thornton each received 60,000 options.
- Exercise price of $0.18 is based on December 29, 2023 closing price.
- Options vest in three equal annual tranches; non-employee directors waived their grants.
- All options fully vest upon a change of control.
- Total options granted to executive officers: 180,000.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1367083/000168316823009150/0001683168-23-009150-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1367083/000168316823009150/sonoma_8k.htm
  HTML page:      https://secwatch.observer/filing/0001683168-23-009150

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer